Pulmozyme — Medical Mutual

Initial criteria

• The medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis

Reauthorization criteria

• A response to therapy is required for continuation of therapy

Approval duration

365 days